The WasteWatcher
Occupational Licensing Executive Order Will Benefit Utah Workers
Utah's new governor and lieutnenant governor signed an executive order requiring state agencies to review occupational licenses to ensure they are necessary and not outdated by June 30, 2021.
PBMs File Complaint Against Unwise HHS Rebate Rule
Introducing more private competition will do far more to lower drugs costs for both beneficiaries and taxpayers.
A Bumpy Ride Ahead on Healthcare Policy
Boosted by their double win in Georgia for two Senate seats, the Democrats will control the legislative and executive branches of government.
President Trump’s Occupational Licensing EO Will Create Jobs Across the Country
State and local governments will have to issue a license to those who hold a license for their area of discipline.
Top 21 Issues for States in 2021
As states prepare for their legislative sessions, CAGW suggests states should focus on these 21 critical issues.
Bad Policies Are Being Proposed by HHS Secretary Nominee Xavier Becerra
The first clue that Joe Biden, the presumptive 46th President of the United States, was choosing someone he did not know well as his nominee for secretary of HHS was when he mispronounced his name and incorrectly named the agency he would direct.
FCC Commences C-Band Auction
On February 28, 2020, the FCC adopted a report and order designating a portion of the c-band spectrum to be auctioned for 5G deployment.
Canada Says Drug Imports Are Not Happening
Importing supposedly less expensive drugs from Canada was a fool’s errand and a waste of valuable federal and state tax dollars.
Critical Waste Issues for Defense Authorization Conferees
Congress is currently negotiating the final bill language for the fiscal year 2021 National Defense Authorization Act.
Pai’s Policies at the FCC Should Be Continued
It is sad to imagine an FCC without the candor, intelligence, and wit of the outgoing Chairman.
New Rules Will Fail to Lower Drug Prices
On Friday, November 20, President Trump announced two interim rules that he claims will lower drug costs in Medicare Parts B and D. That is not accurate.
Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research
Back in September, President Trump signed an Executive Order ordering the Department of Health and Human Services to implement a most favored nation (MFN) policy for pharmaceutical reimbursement in Medicare.